The Molecular Pathology Section study paralogous DNA binding proteins CTCF and BORIS (also known as CTCFL) in 3D genome organization and gene regulation in normal and pathological contexts including; spermatogenesis, evolution, development and cancer.
Victor Lobanenkov, Ph.D.
Chief, Molecular Pathology Section
Ph.D., 1981, Cancer Research Center, Moscow
M.A., 1977, Institute of Physics, UK
Liron M. Fedida, B.A. (He/Him/His)
B.A., City University of New York, Queens College, United States
Languages Spoken: Hebrew
Yon Ji, Ph.D. (She/Her/Hers)
Senior Research Associate
Ph.D., Gwangju Institute of Science and Technology, South Korea
Languages Spoken: Korean
Dmitri Loukinov, Ph.D.
Ph.D., Institute of Biochemistry, Ukrainian Academy of Sciences, Ukraine
Languages Spoken: Ukrainian, French, Russian
Emma Price, Ph.D. (She/Her/Hers)
Visiting Fellow/Postdoctoral Research Fellow
Ph.D., Institute of Systems, Molecular and Integrative Biology, University of Liverpool, United Kingdom
Elena M. Pugacheva, Ph.D. (She/Her/Hers)
Ph.D., Faculty of Biology, Lomonosov Moscow State University, Russia
Languages Spoken: Russian
Kaushlendra Tripathi, Ph.D. (He/Him/His)
Ph.D., Centre for Cellular & Molecular Biology, India
Languages Spoken: Hindi